# Aspirin and Plavix Following Coronary Artery Bypass Grafting

> **NCT01158703** · PHASE4 · TERMINATED · sponsor: **Ahmad Slim** · enrollment: 20 (actual)

## Conditions studied

- Coronary Graft Patency

## Interventions

- **DRUG:** clopidogrel
- **DRUG:** sugar pill
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT01158703
- **Lead sponsor:** Ahmad Slim
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** poor recruitment and reduction in CT surgery support
- **Last updated:** 2015-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01158703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01158703, "Aspirin and Plavix Following Coronary Artery Bypass Grafting". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01158703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*